Our data show that the relative expression of ARO, STS, and HSD17B1 vary in endometriotic tissue obtained from deep infiltrating lesions (DIE), superficial (SUP), ovarian (OMA), and eutopic endometrium from endometriosis patients (EE) lend support to the hypothesis. This evidence concerns the gene CYP19A1 and endometriosis.